Literature DB >> 20482707

Risk for contrast nephropathy in patients undergoing coronarography.

Gaetano La Manna1, Leonardo Goffredo Pancaldi, Alessandro Capecchi, Edlira Maska, Giorgia Comai, Maria L Cappuccilli, Elisa Carretta, Alessandro Lombardi, Luigi Colì, Sergio Stefoni.   

Abstract

Among the causes of in-hospital acute renal failure, contrast-induced nephropathy ranks third in prevalence. Although it represents a condition of renal impairment with spontaneous recovery, contrast nephropathy should always be considered, because it prolongs hospitalization and it may become a severe complication requiring dialysis. The purposes of this study are: (i) to determine if the application of the most effective contrast-induced nephropathy prevention strategies in the Cardiology Intensive Care Unit can prove to be successful in reducing nephropathy risk; and (ii) to identify which of the involved risk factors persist after the preventive treatment. We examined the patients who had a coronarography at the Bentivoglio hospital from April 2007 to April 2008 who required at least 3 days of permanence in hospital due to the presence of potential risk factors; 136 out of 784 patients were included. Among the selected patients, 21 (15.44%) developed a renal impairment compatible with contrast-induced nephropathy. The risk factors that seemed to display the best correlation with risk of contrast nephropathy were advanced age and an ventricular failure (ejection fraction <40%); however, the critical condition did not appear to be due to a single risk factor, but it resulted from the association of more contextual risk factors. Particularly, the concomitant presence of ventricular failure, anemia, diabetes, previous myocardial infarction and advanced age (>70 years) determined a threefold increased risk of contrast nephropathy. Our data suggest that the development of contrast nephropathy following coronarography is associated with worse renal function during hospitalization and at discharge.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20482707     DOI: 10.1111/j.1525-1594.2009.00984.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  11 in total

1.  Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working Group.

Authors:  Iwao Ohno; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Naoki Kashihara; Hirokazu Okada; Yasuhiro Komatsu; Shozo Tamura; Kazuo Awai; Yasuyuki Yamashita; Ryohei Kuwatsuru; Atsushi Hirayama; Yoshihiko Saito; Toyoaki Murohara; Nagara Tamaki; Akira Sato; Tadateru Takayama; Enyu Imai; Yoshinari Yasuda; Daisuke Koya; Yoshiharu Tsubakihara; Shigeo Horie; Yukunori Korogi; Yoshifumi Narumi; Katsumi Hayakawa; Hiroyuki Daida; Koichi Node; Isao Kubota
Journal:  Clin Exp Nephrol       Date:  2013-08       Impact factor: 2.801

2.  Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. JSN, JRS, and JCS Joint Working Group.

Authors:  Iwao Ohno; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Naoki Kashihara; Hirokazu Okada; Yasuhiro Komatsu; Shozo Tamura; Kazuo Awai; Yasuyuki Yamashita; Ryohei Kuwatsuru; Atsushi Hirayama; Yoshihiko Saito; Toyoaki Murohara; Nagara Tamaki; Akira Sato; Tadateru Takayama; Enyu Imai; Yoshinari Yasuda; Daisuke Koya; Yoshiharu Tsubakihara; Shigeo Horie; Yukunori Korogi; Yoshifumi Narumi; Katsumi Hayakawa; Hiroyuki Daida; Koichi Node; Isao Kubota
Journal:  Jpn J Radiol       Date:  2013-08       Impact factor: 2.374

3.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Clin Exp Nephrol       Date:  2020-01       Impact factor: 2.801

4.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Jpn J Radiol       Date:  2020-01       Impact factor: 2.374

5.  Contrast-induced nephropathy (CIN) of patients with renal dysfunction in CT examination.

Authors:  Yasuhiro Fukushima; Hitomi Miyazawa; Junpei Nakamura; Ayako Taketomi-Takahashi; Takayuki Suto; Yoshito Tsushima
Journal:  Jpn J Radiol       Date:  2017-05-20       Impact factor: 2.374

6.  The preventive effect of pentoxifylline on contrast-induced nephropathy: a randomized clinical trial.

Authors:  Vahideh Yavari; Mohammad Ali Ostovan; Javad Kojuri; Raha Afshariani; Alireza Hamidian Jahromi; Alireza Hamidian; Jamshid Roozbeh; Maryam Pakfetrat
Journal:  Int Urol Nephrol       Date:  2013-04-10       Impact factor: 2.370

Review 7.  Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review.

Authors:  Maurizio Sessa; Claudia Rossi; Annamaria Mascolo; Cristina Scavone; Gabriella di Mauro; Roberto Grassi; Liberata Sportiello; Salvatore Cappabianca; Concetta Rafaniello
Journal:  Ther Clin Risk Manag       Date:  2017-10-24       Impact factor: 2.423

Review 8.  Coronary Atherosclerosis Imaging.

Authors:  Michael Y Henein; Sergio Vancheri; Gani Bajraktari; Federico Vancheri
Journal:  Diagnostics (Basel)       Date:  2020-01-24

9.  Independent predictors of acute kidney injury in patients with acute coronary syndrome after percutaneous coronary intervention.

Authors:  Aisulu Zhunuspekova; Jamilya Mansurova; Lyudmila Karazhanova
Journal:  PLoS One       Date:  2021-03-04       Impact factor: 3.240

10.  Urotensin-II and endothelin-I levels after contrast media administration in patients undergoing percutaneous coronary interventions.

Authors:  Turgay Ulas; Hakan Buyukhatipoglu; Mehmet S Dal; Idris Kirhan; Zekeriya Kaya; Mehmet E Demir; Irfan Tursun; Mehmet A Eren; Timucin Aydogan; Yusuf Sezen; Nurten Aksoy
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.